Vitale, A., V. Caggiano, M. C. Maggio, G. Lopalco, G. Emmi, J. Sota, F. La Torre, P. Ruscitti, E. Bartoloni, and G. Conti,
AB0431 CANAKINUMAB AS FIRST-LINE BIOLOGICAL THERAPY IN STILL’S DISEASE AND DIFFERENCES BETWEEN THE SYSTEMIC AND THE CHRONIC-ARTICULAR COURSES: REAL-LIFE EXPERIENCE FROM THE INTERNATIONAL AIDA REGISTRY,
: BMJ Publishing Group Ltd, 2023.
Abstractn/a
Elfishawi, M. M., F. T. Elgengehy, G. I. Mossallam, S. M. Elfishawi, M. M. Alfishawy, and I. M. Metwally,
AB0556 HLA Revisited in Egyptian Patients with Behçet9s Syndrome: New Associations of Hla Alleles with Susceptibility, Protection, Presentation and Severity of The Disaese,
: BMJ Publishing Group Ltd, 2016.
Abstractn/a
Eissa, M., Y. El Miedany, W. Hassan, D. Mekkawy, M. A. Mortada, S. I. Nasef, M. El Gaafary, hala lotfy, yomna farag, G. El Deriny, et al.,
AB0962 UPDATE FOR THE CLINICAL PRACTICE: INTEGRATED, EVIDENCE-BASED APPROACH FOR THE MANAGEMENT OF JUVENILE SPONDYLOARTHRITIS,
: BMJ Publishing Group Ltd, 2019.
Abstractn/a
Eissa, M., Y. El Miedany, W. Hassan, D. Mekkawy, M. A. Mortada, S. I. Nasef, M. El Gaafary, hala lotfy, yomna farag, G. El Deriny, et al.,
AB0962 UPDATE FOR THE CLINICAL PRACTICE: INTEGRATED, EVIDENCE-BASED APPROACH FOR THE MANAGEMENT OF JUVENILE SPONDYLOARTHRITIS,
: BMJ Publishing Group Ltd, 2019.
Abstractn/a
Eissa, M., Y. El Miedany, W. Hassan, D. Mekkawy, M. A. Mortada, S. I. Nasef, M. El Gaafary, hala lotfy, yomna farag, G. El Deriny, et al.,
AB0962 UPDATE FOR THE CLINICAL PRACTICE: INTEGRATED, EVIDENCE-BASED APPROACH FOR THE MANAGEMENT OF JUVENILE SPONDYLOARTHRITIS,
: BMJ Publishing Group Ltd, 2019.
Abstractn/a
Elfishawi, M. M., B. R. Sakr, M. H. El-Arousy, A. K. Hatw, A. N. AbdulKarim, A. B. Tammam, A. N. Kotp, M. E. Hamed, I. E. Genedy, and E. D. El Desouky,
AB1031 Rheumatoid Arthritis, A Single-Center Egyptian Experience,
: BMJ Publishing Group Ltd, 2016.
Abstractn/a
Saeed, D., L. Shalaby, M. Nagy, A. ElZeiny, T. M. Mostafa, M. T. Elrakaiby, M. M. Nooh, A. El-Haddad, M. Abbassi, and R. K. Aziz,
Abstract LB-B19: Investigating the effect of pharmacogenetic variations on voriconazole levels in pediatric cancer patients,
: American Association for Cancer Research, 2019.
Abstractn/a
Kassem, L., S. Omarjee, S. Chabaud, E. Lavergne, C. Faure, F. Beurrier, O. Tredan, L. Corbo, I. Treilleux, and M. Le Romancer,
Abstract P4-11-23: Membranous ERα-36 expression is an independent predictor of poor prognosis in operable breast cancer,
: American Association for Cancer Research, 2015.
Abstractn/a
Kassem, L., L. Fattet, J. Lopez, G. Thibault, E. Lavergne, S. Chabaud, N. Carrabin, N. Chopin, T. Bachelot, and G. Gillet,
Abstract P4-11-24: TIF1 [gamma] interacts with the TGFβ1/SMAD4 signaling leading to poorer outcome in operable breast cancer,
: American Association for Cancer Research, 2015.
Abstractn/a